BR9810734A - Adesivo para emplastro percutaneamente absorvìvel e emplastro percutaneamente absorvìvel - Google Patents

Adesivo para emplastro percutaneamente absorvìvel e emplastro percutaneamente absorvìvel

Info

Publication number
BR9810734A
BR9810734A BR9810734-8A BR9810734A BR9810734A BR 9810734 A BR9810734 A BR 9810734A BR 9810734 A BR9810734 A BR 9810734A BR 9810734 A BR9810734 A BR 9810734A
Authority
BR
Brazil
Prior art keywords
adhesive
percutaneously absorbable
plaster
crotamiton
weight
Prior art date
Application number
BR9810734-8A
Other languages
English (en)
Inventor
Higo Naruto
Hirano Munehiko
Shinmura Miyuki
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of BR9810734A publication Critical patent/BR9810734A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: <B>"ADESIVO PARA EMPLASTRO PERCUTANEAMENTE ABSORVìVEL E EMPLASTRO PERCUTANEAMENTE ABSORVìVEL"<D>. Esta invenção apresenta um adesivo para um emplastro percutaneamente absorvível e também um emplastro percutaneamente absorvível que são capazes de conter uma concentração elevada de crotamiton. O adesivo contém crotamiton e pirotiodecano como um compatibilizador e, especialmente, contém de 10 a 40% em peso de um copolímero em bloco elástico de um tipo (A-B)~ n~-A, 10 a 45% em peso de parafina líquida, de 3 a 10% em peso de crotamiton e 0,3 a 10% em peso de pirotiodecano como um compatibilizador para crotamiton. O emplastro compreende o adesivo e a droga.
BR9810734-8A 1997-04-07 1998-03-27 Adesivo para emplastro percutaneamente absorvìvel e emplastro percutaneamente absorvìvel BR9810734A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10244797A JP4073517B2 (ja) 1997-04-07 1997-04-07 経皮吸収貼付剤用粘着剤及び経皮吸収貼付剤
PCT/JP1998/001409 WO1998044949A1 (fr) 1997-04-07 1998-03-27 Adhesifs autocollants pour emplatres percutanes et emplatres percutanes

Publications (1)

Publication Number Publication Date
BR9810734A true BR9810734A (pt) 2000-09-12

Family

ID=14327733

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810734-8A BR9810734A (pt) 1997-04-07 1998-03-27 Adesivo para emplastro percutaneamente absorvìvel e emplastro percutaneamente absorvìvel

Country Status (7)

Country Link
EP (1) EP1016417A4 (pt)
JP (1) JP4073517B2 (pt)
KR (1) KR20010006092A (pt)
CN (1) CN1252005A (pt)
BR (1) BR9810734A (pt)
CA (1) CA2284625A1 (pt)
WO (1) WO1998044949A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013081014A1 (ja) * 2011-11-28 2015-04-27 株式会社 ケイ・エム トランスダーム 貼付剤
EP3013775A1 (en) 2013-06-28 2016-05-04 Saudi Basic Industries Corporation Layered fertilizer composition
BR112016017496A2 (pt) 2014-01-29 2017-08-08 Nitto Denko Corp Composição para acelerar a penetração através da pele, preparação para administração transdérmica e preparação de emplastro de pele
RU2016134903A (ru) 2014-01-29 2018-03-01 Нитто Денко Корпорейшн Композиция для ускорения проникновения через кожу, препарат для трансдермального введения и препарат трансдермального пластыря

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0637463B2 (ja) * 1986-01-16 1994-05-18 久光製薬株式会社 アザシクロアルカン誘導体
JP2761542B2 (ja) * 1989-03-31 1998-06-04 テイカ製薬株式会社 コルヒチン含有外用製剤
US5770221A (en) * 1994-05-18 1998-06-23 Hisamitsu Pharmaceutical Co., Inc. Formulation for percutaneous administration for treating disturbance in micturition

Also Published As

Publication number Publication date
CA2284625A1 (en) 1998-10-15
EP1016417A1 (en) 2000-07-05
JP4073517B2 (ja) 2008-04-09
WO1998044949A1 (fr) 1998-10-15
KR20010006092A (ko) 2001-01-26
JPH10279474A (ja) 1998-10-20
EP1016417A4 (en) 2001-01-17
CN1252005A (zh) 2000-05-03

Similar Documents

Publication Publication Date Title
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BRPI0414313A (pt) inibidores de citocinas
BR0100046A (pt) Copolìmeros reticulados solúveis em água ou intumescìveis em água
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
BR0306785A (pt) Deazapurinas e seus usos
DE60231868D1 (de) Folat-mimetika und deren folatrezeptorbindende konjugate
BR0313197A (pt) Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
BRPI0515012A (pt) substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
BR0013081A (pt) Pirimidino-2,4,6-trionas inibidoras de metaloproteinases
BRPI0411982A (pt) glicano de aperfeiçoamento de terapia
BRPI0516105A (pt) composições de fator de crescimento derivado de plaqueta e métodos de uso destas
ATE496884T1 (de) Sulphonylaminoessigsaeure derivate und deren verwendung als orexin rezeptor antagoniste
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
UY27760A1 (es) Nuevos derivados de pirrolidinio.
BRPI0511966A (pt) composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons
YU83600A (sh) Adenozin a3 receptorski modulatori
BR9814698A (pt) Combinação de um inibidor da aldose-redutase com um inibidor do glicogênio-fosforilase
BR0111667A (pt) Novos compostos
BR9912073A (pt) Composições farmacêuticas que compreendem 2-quinolonas
ATE335748T1 (de) Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen
SG152257A1 (en) Topical preparation containing ambroxol
BR0003987A (pt) Composição laxativa
EA200500300A1 (ru) Цитотоксические агенты, содержащие новые сильнодействующие таксаны, и их терапевтическое применение
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης

Legal Events

Date Code Title Description
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART 36 DA LPI (LEI 9.279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.